ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021

  • Funded by Biomedical Advanced Research and Development Authority (BARDA)
  • Total publications:0 publications

Grant number: 75A50124F61011

Grant search

Key facts

  • Disease

    Influenza caused by Influenza A virus subtype H5
  • Start & end year

    2024
    2024
  • Known Financial Commitments (USD)

    $680,955
  • Funder

    Biomedical Advanced Research and Development Authority (BARDA)
  • Research Location

    United States of America
  • Lead Research Institution

    SANOFI VACCINES US INC.
  • Research Priority Alignment

    N/A
  • Research Category

    13
  • Research Subcategory

    N/A
  • Special Interest Tags

    N/A
  • Study Type

    Not applicable
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021